NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY – Get Free Report) crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $0.00 and traded as high as $0.73. NovaBay Pharmaceuticals shares last traded at $0.71, with a volume of 31,322 shares traded.
NovaBay Pharmaceuticals Stock Down 2.8 %
The firm has a market cap of $2.95 million, a PE ratio of -0.07 and a beta of 2.82.
NovaBay Pharmaceuticals Company Profile
NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.
Featured Articles
- Five stocks we like better than NovaBay Pharmaceuticals
- Stock Sentiment Analysis: How it Works
- Tesla Investors Continue to Profit From the Trump Trade
- Most active stocks: Dollar volume vs share volume
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for NovaBay Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovaBay Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
